Neuroactive drugs show promising anti-glioblastoma effects in preclinical trials
Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the treatment of glioblastoma. Vortioxetine, an antidepressant, showed promising anti-glioblastoma activity, significantly reducing tumor size in preclinical trials.
24 Sep 04:20 · News-Medical